2014

The following presentation contains forward-looking statements, which express the current beliefs and expectations of management. Such statements involve a number of known and unknown risks and uncertainties that could cause our future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements.Important factors that could cause or contribute to such differences include risks relating to:our ability to develop and commercialize additional pharmaceutical products, competition from competing generic equivalents and due to increased governmental pricing pressures, the effects of competition on sales, and uncertainties surrounding the legislative and regulatory policy.

Forward Looking Statements

MedicineREKAH Pharmaceutical Industries Ltd is engaged in manufacturing, importing, marketing and distribution of prescription drugs, OTC drugs, dermatological preparations, cosmetics, vitamins and nutritional supplements and para-medical products.

ExperienceEstablished in 1946, Rekah boasts a long record of pioneer activity in Israel’s pharmaceutical industry, and has amassed vast and diverse experience in the development, production and sale of generic drugs.Annual turnover exceeds US $80 Million with Equity capital of US $23 Million.

Creation REKAH manufactures a wide variety of 280 different pharmaceutical products (about 16 million units per year), which provide an effective pharmaceutical solution to a variety of medical problems.

Nice To Meet

HealthREKAH is a major player in the Israeli vitamins market and has an exclusive agreement with Clalit- largest health fund in Israel.

DiversityREKAH’s customers in the business sector are diverse and include all institutions active in Israel’s health market.

Leadership REKAH group is responsible for manufacturing, representing and distributing quite many market leading products and popular brands.

Human AssetsThe Group employs 650 employees in all of its divisions and subsidiaries

Nice To Meet

We believein the right of each and every person

to access essential pharmaceuticals and health products,of the highest quality and at affordable prices.

Consequently, we wish to develop and expand the rangeof our products; to lead product innovation;

to expand our activity to new fields and over the seas markets and to establish the REKAH group as a central professional

pharmaceutical industry in Israel.

Vision and Core Values

1984 > Established marketing and distribution company in Jerusalem.

1993 > Acquisition of “Rekah Pharmaceuticals Ltd.” -manufacture unique pills, sterile ointments and steroids.

1994 > Listed for trading on the Tel Aviv Stock Exchange.

1997 > Establishment of a national distribution mechanism.

1999 > Acquisition of “Center Pharm Ltd.” -a retail pharmacy chain (drug stores) countrywide.

Principal Milestones1984-1999

2003 > Acquisition of “Vitamed Pharmaceutical Industries” -manufacture of antibiotic products, ophthalmological products, dermatological ointments, galenics, dermo-cosmetics and vitamins and nutritional supplements.

2009 > Implementation of investment plan Stage A in the production division.

2010 > Establishment of the Group’s main logistics center in the Modiin Industrial Zone.

2012 > Consolidation of production facilities on Holon and Binyamina.

2013-2014 > Expanding R&D and implementation of investment plan Stage B in the production division.

Principal Milestones2000-2014

“Derech Haim”LifestyleHouses

Center Pharm

General Field (Toiletries,

para-medical,general)

Nature Products& Vitamins

PharmaceuticalField Marketing

& Sales Arm

Logistic &Distribution

Arm

General Distribution

Sector

Rekah Production Site/ Holon

Vitamed Production

Site/ Binyamina

ProductionDivisionMarketing, Sales &

Distribution DivisionRetail Division

Rekah Pharmaceutical Industry Ltd.

REKAH Group in 2013 by Activity TypeData in US $ Million

2013 Net Sales: US$ 78.26 million

Production Division for Institutional market

9.83

Retail Division20.02

Special Distribution sector2.93

Marketing Division- others21.65

Marketing Division- private market

17.42

Marketing Division- Clalit Health Fund

private label8.55

Production Division

Vitamins Import arm

Manufacture and Import of OTC and Rx Drugs,Dermo-Cosmetics and Vitamins

R&D armProduction

arm

Production Division

Two production sites at Holon and Binyamina, additional development reserve at Or Akiva.

About 15,000 sqm production areas.

510 marketing authorizations and 14 in the process of authorization.

Basis for future export: export licenses to12 countries.

43% of drug sales are OTC products &57% are Rx products.

Production Division

16 million units produced per year

10 production departments with different technologies (sterile, pills, liquids, creams and powders)

Excess market demand for our products (in the process of expanding production capacity)

Complies with strict pharmaceutical and quality control standards (GMP, ISO, HACCP)

Production Division- R & D

Advanced labs complex

Strong ability to develop and license new products

High quality human assets and vast experience in the pharmaceutical market

License to manufacture and market exclusively a patent product indicated for chemical defense

Strategic cooperation in R&D

Marketing and Sales Division

Marketing and sales of pharm, para-medical, natural

and general products

Marketing and sales arm

Logisticarm

Marketing and Sales Division

2012 Annual income turnover US $47.71 Million.

Marketing and sales force -62 specialized workers, headquarter and field.

Marketing drugs, cosmetics, para-medical and natural products to pharmacies, drugstores, food retail market, health funds, hospitals and senior citizens’ houses.

Extensive marketing activity in the area of vitamins and nutritional supplements for Clalit Health Fund, under the “Derech Haim” private label.

Marketing and Sales Division

Marketing, sales and/or distribution of a series of leading brands - private pharmacies segment.

Portfolio of 3,000 synergetic products-significant sales force.

Logistic center- modern, spacious, efficient with potential to expand (area and activities)

Independent distribution service -1,000 customers on a daily basis.

Productsmain therapeutic fields

Disinfection, Wounds Treatment, Burns and Insect BitesMuscle and Joint PainSkin DrynessBabies: Nappy Change Creams

Vitamins and Nutritional SupplementsAnemia and Nutritional deficiencies

AntibioticsSteroid Anti-InflammatoriesFungal InfectionsUrinary Tract Pain

Eye InfectionsGlaucoma, Dryness and Eye Allergies

Nausea and VomitingMotion SicknessDiarrheaHeartburnDepression and Anxiety

Cough, Expectoration and BronchitisFever and Pain ReliefRunny Nose and CongestionEar Pain

STRATEGY AND

GROWTHENGINES

STRATEGY AND

GROWTHENGINES

Strategy and Growth EnginesExpanding production capacity.

Fast response to excess demand.

Expanding Natural products and vitamins range.

Focus and specialization at pharm products (OTC, Dermatology, Babies line)

Organizational processes of mechanization and automization, synergy and efficiency.SHORT

TERM

Specialization at the core areas of the production division

Implementation of a five year generic R&D plan and know-how agreements

Expanding the portfolio - development and registration of new generic drugs

Branding and marketing- Branded Generics

MEDIUMTERM

Strategy and Growth Engines

LONGTERM

R&D

Product and technology innovation

Export

Strategy and Growth Engines

HQ Address: 30 Hamelacha St. Holon, Israel 58859 Tel: +972-3-5581233 e-mail: merav@rekah.co.il